Prota cracks $20m raising for its allergy treatment
MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 testing for… read more
Terms out for Microba IPO and investors are not happy
BRISBANE: Gut health biotech Microba’s brokers have blasted the terms of its $30 million initial… read more
14 new senior healthcare executives sought for key roles
MELBOURNE: Fourteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
